Lenalidomide and Pomalidomide Improve Function and Induce FcγRI/CD64 in Multiple Myeloma Neutrophils
<b>Background</b> Myeloid dysfunction is an emerging hallmark of microenvironment changes occurring in multiple myeloma (MM). Our previous work showed that FcγRI/CD64 overexpression in neutrophils of newly diagnosed MM patients is associated to inferior outcomes, reduced oxidative bursts...
Main Authors: | Alessandra Romano, Nunziatina Laura Parrinello, Marina Parisi, Vittorio Del Fabro, Angelo Curtopelle, Salvatore Leotta, Concetta Conticello, Francesco Di Raimondo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/10/1455 |
Similar Items
-
Efficiency of pomalidomide therapy in patients with multiple myeloma refractory to lenalidomide
by: I. G. Rekhtina, et al.
Published: (2019-04-01) -
Serum free light chains and multiple myeloma: Is it time to extend their application?
by: Uros Markovic, et al.
Published: (2020-04-01) -
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
by: Vittorio Del Fabro, et al.
Published: (2023-08-01) -
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
by: Cirino Botta, et al.
Published: (2021-04-01) -
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
by: Uros Markovic, et al.
Published: (2019-09-01)